Prospects for Gilead Sciences' Trodelvy in hormone receptor-positive, HER2-negative metastatic breast cancer continue to improve as data from the TROPiCs-02 trial strengthen, but the jury is still ...

Just over a week after Madrid welcomed thousands to discuss the latest developments in endocrinology at EASD 2024, Spain also took the lead on oncological proceedings this September, playing host ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.